Diana O. Perkins, MD

Improving Adherence to Schizophrenia Treatment

March 26, 2019

Relapse of schizophrenia often occurs due to treatment nonadherence. Long-acting injectable (LAI) antipsychotics can improve adherence but are underused. Watch this Webcast to hear interviews with patients and learn...

Diana O. Perkins, John Lauriello

Academic Highlights

Continuous Care for Schizophrenia

February 19, 2019

Even brief interruptions in treatment can significantly increase a schizophrenia patient's risk of psychotic relapse. Read this Academic Highlights to discover the complex factors that can contribute to treatment...

John Lauriello, Diana O. Perkins

Educational Activity

Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?

December 27, 2017

Diana O. Perkins

Article

Proceedings and Data From The Schizophrenia Summit: A Critical Appraisal to Improve the Management of Schizophrenia

March 4, 2009

Diana O. Perkins, Peter J. Weiden, John M. Kane, et al

Original Research

Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder: A Randomized, Double-Blind, Flexible-Dose, Multicenter Study

January 15, 2008

Diana O. Perkins, Peter J. Weiden, Joseph P. McEvoy, et al

Article

Introduction. Quetiapine: A 5-Year Update

December 31, 2002

Diana O. Perkins, Jeffrey A. Lieberman

Original Research

Predictors of Noncompliance in Patients With Schizophrenia

December 1, 2002

Diana O. Perkins

Article

Adherence to Antipsychotic Medications

August 1, 1999

Diana O. Perkins

Improving Adherence to Schizophrenia Treatment

Continuous Care for Schizophrenia

Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?

Proceedings and Data From The Schizophrenia Summit: A Critical Appraisal to Improve the Management of Schizophrenia

Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder: A Randomized, Double-Blind, Flexible-Dose, Multicenter Study

Introduction. Quetiapine: A 5-Year Update

Predictors of Noncompliance in Patients With Schizophrenia

Adherence to Antipsychotic Medications

ELSEWHERE:

FOLLOW US:

Diana O. Perkins, MD

Improving Adherence to Schizophrenia Treatment

Continuous Care for Schizophrenia

Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?

Proceedings and Data From The Schizophrenia Summit: A Critical Appraisal to Improve the Management of Schizophrenia

Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder: A Randomized, Double-Blind, Flexible-Dose, Multicenter Study

Introduction. Quetiapine: A 5-Year Update

Predictors of Noncompliance in Patients With Schizophrenia

Adherence to Antipsychotic Medications

Learn More About Psychedelics in Psychiatry

Subscribe to readmore articles

Subscribe to read
more articles